The FMS-like tyrosine kinase 3 (FLT3) gene is mutated in approximately 30% of patients with acute myeloid leukemia (AML) and...

COSTEM: maintenance therapies for FLT3+ AML

The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review!  For more news visit www.vjhemonc.com

Medicine

Health & Fitness

The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com

Share COSTEM: maintenance therapies for FLT3+ AML

Sign up to save your podcasts

COSTEM: maintenance therapies for FLT3+ AML

COSTEM: maintenance therapies for FLT3+ AML

More shows like VJHemOnc Podcast

Hematologic Oncology Update

Mayo Clinic Talks

The Curbsiders Internal Medicine Podcast

Blood Podcast

CCO Oncology Podcast

Blood Cancer Talks

Two Onc Docs

All Things Amyloid

The Hematology Podcast Series!